Quarterly report pursuant to Section 13 or 15(d)

SHARE-BASED COMPENSATION - (Details)

v3.23.1
SHARE-BASED COMPENSATION - (Details) - USD ($)
1 Months Ended 3 Months Ended
Jan. 31, 2022
Feb. 28, 2023
Apr. 30, 2022
Jul. 31, 2021
Jun. 30, 2021
Mar. 31, 2023
Mar. 31, 2022
Apr. 30, 2021
Share-based compensation                
Stock options granted (in shares)           467,500    
Grant exercise price (in dollars per share)           $ 3.41    
Total compensation expense not yet recognized           $ 4,824,706    
Weighted average vesting period           1 year 10 months 17 days    
Intrinsic value of stock option           $ 23,375    
Weighted average contractual life           8 years 6 months 10 days    
June 2021                
Share-based compensation                
Share based compensation expense           $ 181,720 $ 181,720  
Common stock shares available (in shares)         807,500      
Grant exercise price (in dollars per share)         $ 6.26      
June 2021 | Employee | Tranche one                
Share-based compensation                
Vesting percentage         40.00%      
June 2021 | Employee | Tranche two                
Share-based compensation                
Vesting term of options         36 months      
July 2021                
Share-based compensation                
Share based compensation expense           490,916 490,916  
Stock options granted (in shares)       1,550,000        
Grant exercise price (in dollars per share)       $ 6.18        
July 2021 | Executive officers | Tranche one                
Share-based compensation                
Vesting percentage       25.00%        
July 2021 | Executive officers | Tranche two                
Share-based compensation                
Vesting term of options       36 months        
July 2021 | Independent Directors, Consultant                
Share-based compensation                
Vesting term of options       36 months        
January 2022                
Share-based compensation                
Share based compensation expense           18,950 88,433  
Stock options granted (in shares) 80,000              
Grant exercise price (in dollars per share) $ 4.44              
January 2022 | Tranche one                
Share-based compensation                
Vesting percentage 25.00%              
January 2022 | Tranche two                
Share-based compensation                
Vesting term of options 36 months              
April 2022                
Share-based compensation                
Share based compensation expense           5,378 $ 0  
Stock options granted (in shares)     30,000          
Grant exercise price (in dollars per share)     $ 3.79          
April 2022 | Tranche one                
Share-based compensation                
Vesting percentage     25.00%          
April 2022 | Tranche two                
Share-based compensation                
Vesting term of options     36 months          
February 2023                
Share-based compensation                
Share based compensation expense           $ 36,507    
Stock options granted (in shares)   467,500            
Grant exercise price (in dollars per share)   $ 3.41            
Vesting term of options   36 months            
2021 Equity Incentive Plan                
Share-based compensation                
Common stock shares reserved               2,874,063
Common stock shares available (in shares)           535,868